{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:50:15Z","timestamp":1789656615220,"version":"4.0.1"},"reference-count":97,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.ejphar.2011.09.167","type":"journal-article","created":{"date-parts":[[2011,9,25]],"date-time":"2011-09-25T21:55:42Z","timestamp":1316987742000},"page":"26-32","source":"Crossref","is-referenced-by-count":20,"title":["Differential effects of subtype-specific nicotinic acetylcholine receptor agonists on early and late hippocampal LTP"],"prefix":"10.1016","volume":"671","author":[{"given":"Katja S.","family":"Kroker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Rast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Rosenbrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.09.167_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2006.12.009","article-title":"Electrical stimulation protocols for hippocampal synaptic plasticity and neuronal hyper-excitability: are they effective or relevant?","volume":"204","author":"Albensi","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0079-6123(03)45007-3","article-title":"The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex","volume":"145","author":"Alkondon","year":"2004","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0015","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1523\/JNEUROSCI.19-07-02693.1999","article-title":"Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices","volume":"19","author":"Alkondon","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0020","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1523\/JNEUROSCI.18-20-08485.1998","article-title":"Nicotine selectively enhances NMDA receptor-mediated synaptic transmission during postnatal development in sensory neocortex","volume":"18","author":"Aramakis","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0025","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.bcp.2007.06.033","article-title":"Neuronal nicotinic receptors: a perspective on two decades of drug discovery research","volume":"74","author":"Arneric","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0030","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/npp.2008.232","article-title":"Pro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia","volume":"34","author":"Barak","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/349156a0","article-title":"Long-term potentiation of NMDA receptor-mediated synaptic transmission in the hippocampus","volume":"349","author":"Bashir","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.npp.1301189","article-title":"SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile","volume":"32","author":"Biton","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/361031a0","article-title":"A synaptic model of memory: long-term potentiation in the hippocampus","volume":"361","author":"Bliss","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ddr.10352","article-title":"In vitro and in vivo characterization of TC-1827, a novel brain \u03b14\u03b22 nicotinic receptor agonist with pro-cognitive activity","volume":"62","author":"Bohme","year":"2004","journal-title":"Drug Dev. Res."},{"issue":"6 Suppl","key":"10.1016\/j.ejphar.2011.09.167_bb0055","first-page":"S85","article-title":"Novel analogs of choline as potential neuroprotective agents","volume":"6","author":"Buccafusco","year":"2004","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0060","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.tips.2005.05.007","article-title":"Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic\u2013pharmacodynamic discordance","volume":"26","author":"Buccafusco","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0065","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.neuropharm.2007.03.008","article-title":"Frontal cortical alpha7 and alpha4beta2 nicotinic acetylcholine receptors in working and reference memory","volume":"52","author":"Chan","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1113\/jphysiol.1983.sp014478","article-title":"Excitatory amino acids in synaptic transmission in the Schaffer collateral\u2013commissural pathway of the rat hippocampus","volume":"334","author":"Collingridge","year":"1983","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0485","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(04)16499-4","article-title":"Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial","volume":"363","author":"Courtney","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0490","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0022-3565(25)22339-4","article-title":"(S)-3-methyl-5 (1-methyl-2-pyrrolidinyl)Isoxazole (ABT-418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization","volume":"270","author":"Decker","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0085","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/14728220902841045","article-title":"Nicotinic acetylcholine receptors: an overview on drug discovery","volume":"13","author":"D'hoedt","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0495","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00406-008-0864-1","article-title":"To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease","volume":"259","author":"Diniz","year":"2009","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0095","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1023\/A:1023692705700","article-title":"Epibatidine: impact on nicotinic receptor research","volume":"23","author":"Dukat","year":"2003","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/19978","article-title":"Dendritic spine changes associated with hippocampal long-term synaptic plasticity","volume":"399","author":"Engert","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0105","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.1523\/JNEUROSCI.21-20-07993.2001","article-title":"Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus","volume":"21","author":"Fabian-Fine","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0026-895X(25)08832-7","article-title":"A subtype of nicotinic cholinergic receptors in the rat brain is composed of a4 and b2 subunits and is up-regulated by chronic nicotine treatment","volume":"41","author":"Flores","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0120","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1476-5381.1996.tb15245.x","article-title":"Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices","volume":"117","author":"Frankiewicz","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0125","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/1096-8628(20010108)105:1<20::AID-AJMG1047>3.0.CO;2-C","article-title":"Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7)","volume":"105","author":"Freedman","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-8993(88)90008-X","article-title":"Anisomycin, an inhibitor of protein-synthesis, blocks late phase of LTP phenomena in the hippocampal CA1 region in vitro","volume":"452","author":"Frey","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0135","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1523\/JNEUROSCI.0542-05.2005","article-title":"Nicotinic acetylcholine receptors at glutamate synapses facilitate long-term depression or potentiation","volume":"25","author":"Ge","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0140","first-page":"60","article-title":"Ispronicline (Targacept)","volume":"7","author":"Geerts","year":"2006","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00213-010-2153-8","article-title":"Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings","volume":"215","author":"Graef","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0150","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1113\/jphysiol.2002.035436","article-title":"Amyloid beta(1\u201342) peptide alters the gating of human and mouse alpha-bungarotoxin-sensitive nicotinic receptors","volume":"547","author":"Grassi","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0155","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/383713a0","article-title":"Hippocampal synaptic transmission enhanced by low concentrations of nicotine","volume":"83","author":"Gray","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0160","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuropharm.2009.05.003","article-title":"Atypical antipsychotics as noncompetitive inhibitors of \u03b14\u03b22 and \u03b17 neuronal nicotinic receptors","volume":"57","author":"Grinevich","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0165","doi-asserted-by":"crossref","first-page":"538","DOI":"10.2174\/138161210790361434","article-title":"Targeting alpha7 nicotinic acetylcholine receptors in the treatment of schizophrenia","volume":"16","author":"Haj\u00f3s","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0500","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.biopsych.2007.04.034","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711","volume":"63","author":"Hashimoto","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0170","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.bcp.2009.05.030","article-title":"TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia","volume":"78","author":"Hauser","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0180","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2174\/156802610790410983","article-title":"Neuronal nicotinic acetylcholine receptors \u2014 targets for the development of drugs to treat cognitive impairment associated with schizophrenia and Alzheimer's disease","volume":"10","author":"Haydar","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0185","first-page":"e379","article-title":"Cholinesterase inhibitors and the risk of pulmonary disorders in hospitalized dementia patients","volume":"17","author":"Helou","year":"2010","journal-title":"J. Popul. Ther. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0190","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1369-1600.2010.00213.x","article-title":"Cognitive effects of nicotine: genetic moderators","volume":"15","author":"Herman","year":"2010","journal-title":"Addict. Biol."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0195","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1111\/j.1532-5415.2009.02488.x","article-title":"Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system","volume":"57","author":"Hernandez","year":"2009","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0200","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1021\/jm970377o","article-title":"Neuronal nicotinic receptors as targets for drug discovery","volume":"40","author":"Holladay","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0205","doi-asserted-by":"crossref","first-page":"R350","DOI":"10.1016\/S0960-9822(98)70219-2","article-title":"Synaptic plasticity: going through phases with LTP","volume":"8","author":"Huang","year":"1998","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0210","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1101\/lm.1.1.74","article-title":"Recruitment of long-lasting and protein kinase A-dependent long-term potentiation in the CA1 region of hippocampus requires repeated tetanization","volume":"1","author":"Huang","year":"1994","journal-title":"Learn. Mem."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0215","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1101\/lm.3.2-3.74","article-title":"Long-lasting forms of synaptic potentiation in the mammalian hippocampus","volume":"3","author":"Huang","year":"1996","journal-title":"Learn. Mem."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0505","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1152\/jn.2000.83.5.2682","article-title":"Inhibition and disinhibition of pyramidal neurons by activation of nicotinic receptors on hippocampal interneurons","volume":"83","author":"Ji","year":"2000","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0225","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0896-6273(01)00332-4","article-title":"Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity","volume":"31","author":"Ji","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0230","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1460-9568.2009.07058.x","article-title":"Nicotine facilitates long-term potentiation induction in oriens-lacunosum moleculare cells via Ca2+ entry through non-alpha7 nicotinic acetylcholine receptors","volume":"31","author":"Jia","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0240","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1469-7793.1997.603bd.x","article-title":"Functional nicotinic ACh receptors on interneurones in the rat hippocampus","volume":"504","author":"Jones","year":"1997","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0235","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0166-2236(99)01471-X","article-title":"Nicotinic receptors in the brain: correlating physiology with function","volume":"22","author":"Jones","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0245","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/bmj.331.7512.321","article-title":"Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials","volume":"331","author":"Kaduszkiewicz","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0250","doi-asserted-by":"crossref","first-page":"9024","DOI":"10.1523\/JNEUROSCI.23-27-09024.2003","article-title":"Functional mapping and Ca2+ regulation of nicotinic acetylcholine receptor channels in rat hippocampal CA1 neurons","volume":"23","author":"Khiroug","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0255","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neulet.2007.03.016","article-title":"The alpha7 nicotinic receptor agonist SSR180711 increases activity regulated cytoskeleton protein (Arc) gene expression in the prefrontal cortex of the rat","volume":"418","author":"Kristensen","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0265","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.neuropharm.2011.05.014","article-title":"Differential effect of the mGlu5 receptor positive allosteric modulator ADX-47273 on early and late hippocampal LTP","volume":"61","author":"Kroker","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0260","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jneumeth.2010.11.006","article-title":"A multi-slice recording system for stable late phase hippocampal long-term potentiation experiments","volume":"194","author":"Kroker","year":"2011","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0270","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.pharmthera.2009.03.009","article-title":"A cog in cognition: how the alpha 7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits","volume":"122","author":"Leiser","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0910","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02740634","article-title":"Nicotinic acetylcholine receptors in health and disease","volume":"15","author":"Lindstrom","year":"1997","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0280","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1385\/JMN:30:1:19","article-title":"Ispronicline: a novel alpha4beta2 nicotinic acetylcholine receptor-selective agonist with cognition-enhancing and neuroprotective properties","volume":"30","author":"Lippiello","year":"2006","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0275","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0896-6273(03)00257-5","article-title":"Actin's actions in LTP-induced synapse growth","volume":"38","author":"Lisman","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0285","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0022-3565(24)35314-5","article-title":"Neuronal nicotinic acetylcholine receptors as novel drug targets","volume":"292","author":"Lloyd","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0290","doi-asserted-by":"crossref","first-page":"10250","DOI":"10.1523\/JNEUROSCI.19-23-10250.1999","article-title":"Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus","volume":"19","author":"Lu","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0295","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1113\/jphysiol.2004.067041","article-title":"Persistent decrease in synaptic efficacy induced by nicotine at Schaffer collateral-CA1 synapses in the immature rat hippocampus","volume":"559","author":"Maggi","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0300","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1126\/science.285.5435.1870","article-title":"Long-term potentiation \u2014 a decade of progress?","volume":"285","author":"Malenka","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0305","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0896-6273(00)00042-8","article-title":"Long-term potentiation of excitatory inputs to brain reward areas by nicotine","volume":"27","author":"Mansvelder","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0315","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1126\/science.7569895","article-title":"Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors","volume":"269","author":"McGehee","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0320","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrd2314","article-title":"Therapies for Alzheimer's disease","volume":"6","author":"Melnikova","year":"2007","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0510","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00702-006-0561-z","article-title":"Nicotinic receptor agonists as neuroprotective\/neurotrophic drugs. Progress in molecular mechanisms","volume":"114","author":"Mudo","year":"2007","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0330","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00174504","article-title":"Intravenous nicotine in Alzheimer's disease: a pilot study","volume":"95","author":"Newhouse","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0340","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1101\/lm.4.2.230","article-title":"Brief theta-burst stimulation induces a transcription-dependent late phase of LTP requiring cAMP in area CA1 of the mouse hippocampus","volume":"4","author":"Nguyen","year":"1997","journal-title":"Learn. Mem."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0335","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1126\/science.8066450","article-title":"Requirement of a critical period of transcription for induction of a late phase of LTP","volume":"265","author":"Nguyen","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0345","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0006-3223(00)01125-2","article-title":"Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications","volume":"49","author":"Nordberg","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0350","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.arr.2004.07.002","article-title":"Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNF","volume":"3","author":"Pang","year":"2004","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0355","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0301-0082(99)00045-3","article-title":"Neuronal nicotinic receptors in the human brain","volume":"61","author":"Paterson","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0360","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0741-8329(01)00130-6","article-title":"Nicotinic receptor subtypes in human brain related to aging and dementia","volume":"24","author":"Perry","year":"2001","journal-title":"Alcohol"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-010-1932-6","article-title":"Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature","volume":"212","author":"Philip","year":"2010","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0365","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.npp.1301188","article-title":"80711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia","volume":"32","author":"Pichat","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0370","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1101\/lm.70004","article-title":"Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction","volume":"11","author":"Pidoplichko","year":"2004","journal-title":"Learn. Mem."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0375","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bcp.2009.04.031","article-title":"Nicotinic actions on neuronal networks for cognition: general principles and long-term consequences","volume":"78","author":"Poorthuis","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0905","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bcp.2009.05.003","article-title":"Multiple roles for nicotine in Parkinson's disease","volume":"78","author":"Quik","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0380","doi-asserted-by":"crossref","first-page":"7075","DOI":"10.1523\/JNEUROSCI.18-18-07075.1998","article-title":"Nicotinic stimulation produces multiple forms of glutamatergic synaptic enhancement","volume":"18","author":"Radcliffe","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0385","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/138161210790170166","article-title":"Treating the cognitive deficits of schizophrenia with alpha4beta2 neuronal nicotinic receptor agonists","volume":"16","author":"Radek","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0390","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuropharm.2006.07.026","article-title":"The late maintenance of hippocampal LTP: requirements, phases, \u2018synaptic tagging\u2019, \u2018late-associativity\u2019 and implications","volume":"52","author":"Reymann","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0395","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0006-3223(00)01094-5","article-title":"Cognitive effects of nicotine","volume":"49","author":"Rezvani","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0400","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0896-6273(00)80134-8","article-title":"Nicotinic receptors in the development and modulation of CNS synapses","volume":"16","author":"Role","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0405","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/WAD.0b013e3181b7642b","article-title":"Donepezil-associated bradyarrhythmia in a patient with dementia with Lewy bodies (DLB)","volume":"24","author":"Rosenbloom","year":"2010","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0410","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1212\/WNL.63.8.1543-a","article-title":"Severe worsening of parkinsonism in Lewy body dementia due to donepezil","volume":"63","author":"Rozzini","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0415","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1192\/bjp.154.6.797","article-title":"The effects of nicotine on attention, information processing, and shortterm memory in patients with dementia of the Alzheimer type","volume":"154","author":"Sahakian","year":"1989","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0420","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.bcp.2009.04.019","article-title":"nAChR agonist-induced cognition enhancement: integration of cognitive and neuronal mechanisms","volume":"78","author":"Sarter","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0425","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0028-3908(97)00040-3","article-title":"Modulation of long-term potentiation in CA1 region of mouse hippocampal brain slices by GABAA receptor benzodiazepine site ligands","volume":"36","author":"Seabrook","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0430","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1523\/JNEUROSCI.13-02-00596.1993","article-title":"Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium","volume":"13","author":"S\u00e9gu\u00e9la","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0515","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/neu.1076","article-title":"Agonists cause endocytosis of nicotinic acetylcholine receptors on cultured myotubes","volume":"49","author":"St. John","year":"2001","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0915","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrd2927","article-title":"Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system","volume":"8","author":"Taly","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0440","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/138161210790170094","article-title":"Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology","volume":"16","author":"Thomsen","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0445","first-page":"37","article-title":"\u03b17 nicotinic receptor agonists: potential therapeutic drugs for treatment of cognitive impairments in schizophrenia and Alzheimer's disease","volume":"4","author":"Toyohara","year":"2010","journal-title":"Open Med. Chem. J."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0450","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.neuroscience.2003.09.028","article-title":"Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain","volume":"124","author":"Tribollet","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2011.09.167_bb0460","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1523\/JNEUROSCI.14-09-05514.1994","article-title":"Quantitative measurement of calcium flux through muscle and neuronal nicotinic acetylcholine receptors","volume":"14","author":"Vernino","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0465","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1124\/jpet.110.171892","article-title":"RG3487, a novel nicotinic \u03b17 receptor partial agonist, improves cognition and sensorimotor gating in rodents","volume":"336","author":"Wallace","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0470","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0091-3057(95)00043-V","article-title":"Nicotine patches in Alzheimer's disease: pilot study on learning, memory and safety","volume":"51","author":"Wilson","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0520","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0166-2236(96)10073-4","article-title":"Presynaptic nicotinic ACh receptors","volume":"20","author":"Wonnacott","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2011.09.167_bb0480","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1534582302001001002","article-title":"Neuronal nicotinic acetylcholine receptors: involvement in Alzheimer's disease and schizophrenia","volume":"1","author":"Woodruff-Pak","year":"2002","journal-title":"Behav. Cogn. Neurosci. Rev."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911011502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911011502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T01:03:09Z","timestamp":1741741389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299911011502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":97,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0014299911011502"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.09.167","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}